Frits R Rosendaal Selected Research

Hypertension (High Blood Pressure)

4/2024	Hypertension and diabetes, but not leptin and adiponectin, mediate the relationship between body fat and chronic kidney disease.
1/2023	Opium as a risk factor for early-onset coronary artery disease: Results from the Milano-Iran (MIran) study.
2/2022	Association between cardiovascular risk factors and venous thromboembolism in the elderly.
6/2021	Differential effect of statin use on coagulation markers: an active comparative analysis in the NEO study.
2/2012	Competing risk of atherosclerotic risk factors for arterial and venous thrombosis in a general population: the Tromso study.
11/2009	Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.
12/2003	Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients.
2/2003	Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
4/2002	Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frits R Rosendaal Research Topics

Disease

105	Venous Thrombosis (Deep-Vein Thrombosis) 03/2024 - 01/2002
61	Thrombosis (Thrombus) 12/2020 - 01/2002
37	Obesity 03/2024 - 03/2003
30	Myocardial Infarction 11/2019 - 02/2002
25	Hemorrhage 12/2023 - 04/2002
25	Thrombophilia 05/2021 - 01/2002
24	Venous Thromboembolism 03/2024 - 01/2001
16	Neoplasms (Cancer) 07/2023 - 02/2004
16	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 04/2002
13	Ischemic Stroke 08/2023 - 02/2002
10	COVID-19 03/2024 - 01/2020
10	Inflammation (Inflammations) 10/2023 - 01/2002
9	Hypertension (High Blood Pressure) 04/2024 - 04/2002
9	Hemophilia A (Haemophilia) 01/2024 - 12/2004
9	Infections 07/2023 - 10/2002
9	Pain (Aches) 01/2023 - 11/2003
8	Atrial Fibrillation 01/2021 - 11/2003
7	Osteoarthritis 01/2023 - 05/2005
7	Insulin Resistance 01/2023 - 01/2019
7	Stroke (Strokes) 12/2020 - 04/2002
6	Pulmonary Embolism 03/2014 - 04/2006
6	Activated Protein C Resistance (APC Resistance) 04/2009 - 03/2002
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 01/2018
5	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2016
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 07/2009
5	Overweight 05/2016 - 10/2004
4	Coronary Disease (Coronary Heart Disease) 08/2023 - 11/2008
4	Atherosclerosis 01/2023 - 07/2009
4	Wounds and Injuries (Trauma) 08/2015 - 07/2006
4	Thromboembolism 07/2009 - 11/2003
4	Hyperhomocysteinemia 01/2007 - 10/2002
3	Genetic Risk Score 06/2023 - 10/2017
3	Synovitis 01/2022 - 11/2019
3	Hepatitis C 01/2021 - 12/2004

Drug/Important Bio-Agent (IBA)

27	factor V LeidenIBA 01/2023 - 01/2002
25	Oral ContraceptivesIBA 12/2020 - 05/2002
23	Factor VIII (Coagulation Factor VIII)IBA 07/2023 - 01/2002
22	AnticoagulantsIBA 12/2023 - 04/2002
19	Blood Coagulation Factors (Coagulation Factor)IBA 02/2024 - 03/2003
16	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 01/2006
16	Hormones (Hormone)IBA 01/2021 - 10/2004
15	Triglycerides (Triacylglycerol)IBA 01/2023 - 10/2004
15	Protein CIBA 01/2023 - 06/2003
13	Thrombin FDA Link 02/2024 - 03/2002
13	Prothrombin (Factor II)IBA 01/2023 - 01/2002
13	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2021 - 01/2001
12	von Willebrand FactorIBA 07/2023 - 03/2007
10	LipidsIBA 06/2021 - 10/2004
10	Estrogens (Estrogen)FDA Link 04/2009 - 02/2003
9	Combined Oral ContraceptivesIBA 03/2024 - 02/2003
9	C-Reactive ProteinIBA 01/2023 - 01/2002
9	Insulin (Novolin)FDA Link 11/2021 - 01/2006
9	AntigensIBA 01/2021 - 10/2002
9	HomocysteineIBA 10/2019 - 01/2002
9	Tyr sulfate(1)- enkephalinamide-Leu (LETS)IBA 08/2012 - 01/2002
8	Progestins (Progestagens)IBA 03/2024 - 05/2002
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2007
8	Biomarkers (Surrogate Marker)IBA 05/2021 - 03/2005
8	Factor XIII (Coagulation Factor XIII)IBA 05/2011 - 02/2002
7	Fibrinogen (Factor I)FDA Link 06/2023 - 03/2003
7	Blood Group Antigens (Blood Groups)IBA 01/2023 - 04/2010
7	Opioid Analgesics (Opioids)IBA 01/2023 - 01/2019
7	Levonorgestrel (Plan B)FDA LinkGeneric 10/2020 - 05/2002
6	LeptinIBA 04/2024 - 01/2018
6	AntithrombinsIBA 01/2023 - 06/2003
6	Protein SIBA 01/2023 - 11/2002
5	AdiponectinIBA 04/2024 - 01/2018
5	Contraceptive Agents (Contraceptives)IBA 03/2024 - 02/2003
5	AntibodiesIBA 01/2024 - 12/2004
5	ORALIT (ORS)IBA 01/2023 - 05/2011
5	Hemostatics (Antihemorrhagics)IBA 01/2019 - 01/2002
5	Vitamin K FDA Link 06/2017 - 10/2005
4	VaccinesIBA 06/2023 - 10/2019
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2023 - 01/2013
4	oxidized low density lipoproteinIBA 01/2023 - 01/2019
4	Lipoproteins (Lipoprotein)IBA 01/2022 - 01/2019
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 11/2019
4	fibrin fragment D (D-dimer)IBA 07/2021 - 01/2002
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 03/2007
4	lipoprotein-associated coagulation inhibitor (TFPI)IBA 04/2018 - 02/2006
4	Factor V (Coagulation Factor V)IBA 04/2018 - 10/2004
4	HDL CholesterolIBA 01/2018 - 10/2004
4	CholesterolIBA 01/2016 - 10/2004
4	Desogestrel FDA LinkGeneric 03/2014 - 05/2002
4	GestodeneIBA 03/2014 - 05/2002
4	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2010 - 05/2007
4	PlasminogenIBA 07/2010 - 05/2007
4	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 07/2009 - 02/2007
3	Neutralizing AntibodiesIBA 01/2024 - 05/2016
3	remdesivirIBA 10/2023 - 01/2021
3	Dexamethasone (Maxidex)FDA LinkGeneric 10/2023 - 01/2022
3	InterleukinsIBA 04/2023 - 03/2005
3	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 11/2019
3	CreatinineIBA 11/2021 - 01/2020
3	NucleotidesIBA 01/2021 - 01/2016
3	Messenger RNA (mRNA)IBA 01/2021 - 03/2005

Therapy/Procedure

31	Therapeutics 01/2023 - 04/2002
4	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2015 - 06/2002
4	Central Venous Catheters 01/2008 - 11/2003
3	Arthroplasty 01/2023 - 01/2022